Catheter Precision (VTAK) Income from Non-Controlling Interests (2025 - 2026)
Catheter Precision (VTAK) posted quarterly Income from Non-Controlling Interests of -$9000.0 for Q1 2026, up 87.14% quarter-over-quarter from -$70000.0 in Q4 2025.
Catheter Precision (VTAK) Income from Non-Controlling Interests (2025 - 2026) Analysis & Trends
Catheter Precision (VTAK) has reported Income from Non-Controlling Interests for 2 consecutive years, with -$9000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Income from Non-Controlling Interests changed N/A year-over-year to -$9000.0; the TTM figure through Mar 2026 stood at -$521000.0 (changed N/A YoY), while the FY2025 annual figure was -$512000.0, changed N/A from the prior year.
- Income from Non-Controlling Interests improved to -$9000.0 in Q1 2026 per VTAK's latest filing, from -$70000.0 in the prior quarter.
- Across five years, Income from Non-Controlling Interests topped out at -$9000.0 in Q1 2026 and bottomed at -$349000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 16.00 Mn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | -2.00 Mn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | -500,000.00 |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 13.00 Mn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 2.32 Mn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 900,000.00 |
| 10 | Catheter Precision | 578,118.23 | -1.26 Mn | 98,000.00 | -11,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9,000.00 |
| Dec 31, 2025 | -70,000.00 |
| Sep 30, 2025 | -93,000.00 |
| Jun 30, 2025 | -349,000.00 |